akro: the income statement

MyFinsight

Akero Therapeutics, Inc. (AKRO)

For the quarter ending 2025-06-30, AKRO made $11,540K in revenue. -$70,602K in net income. Net profit margin of -611.80%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Loss from operations	-80,873
Interest expense	1,172
Interest and other income, net	11,540
Net loss	-70,505
Net unrealized gain (loss) on marketable securities	-97
Comprehensive loss	-70,602

Net loss per share, basic	-0.86
Net loss per share, diluted	-0.86
Weighted-average number of shares used in computing net loss per common share, basic	81,721,387
Weighted-average number of shares used in computing net loss per common share, diluted	81,721,387

Unit: Thousand (K) dollars (except for numbers of shares and EPS)